A six-month, open-label study assessing a new formulation of leuprolide 7.5 mg for suppression of testosterone in patients with prostate cancer

Studies on Prostatic Cancer: I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

Charles Huggins, Clarence V. Hodges · The Journal of Urology · 2002 · 3.2K citations

Cancer statistics, 1999

Sarah Landis, Thomas S. Murray, S. Bolden et al. · CA A Cancer Journal for Clinicians · 1999 · 3.1K citations · Full text

Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide

C. Gordon Zubrod, Marvin A. Schneiderman, Emil Frei et al. · Journal of Chronic Diseases · 1960 · 1K citations

Oncology, Medicine, Comparative Therapeutic Trial +9

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.

G. Tolis, DCF ACKMAN, A. Stellos et al. · Proceedings of the National Academy of Sciences · 1982 · 368 citations · Full text

Urology, Growth Hormone, Human Growth +13

FAILURE TO ACHIEVE CASTRATE LEVELS OF TESTOSTERONE DURING LUTEINIZING HORMONE RELEASING HORMONE AGONIST THERAPY: THE CASE FOR MONITORING SERUM TESTOSTERONE AND A TREATMENT DECISION ALGORITHM

Michael G. Oefelein, Rhonda L. Cornum · The Journal of Urology · 2000 · 162 citations